Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Rolling; submission deadlines for subsequent review ocurring on August 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Diamond Blackfan Anemia Foundation – Research Grant

• Due: Rolling
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
• Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.

FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
• Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Hearst Foundations – Funding Priorities in Health

• Due: Rolling
• Funding: $100,000 minimum
• Project period: Not specified
• Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
• Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Malan Syndrome Foundation – Research Grant Program

• Due: Rolling
• Funding: $30,000 per year
• Project period: 1 to 2 years
• Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
• Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals

• Due: Rolling
• Funding: Not specified
• Project Period: 1 to 3 years
• Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
• Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

December

America Brain Tumor Association  – Basic Research Fellowships

• Due : December 10, 2025 (LOI)
• Funding: Up to $100,000
• Project Period: 2 years
• Purpose: To support mentored research by postdoctoral fellows who are conducting laboratory or field-based research projects seeking to advance the scientific understanding of the causes, effects, diagnosis, and medical treatment of brain tumors. Research may include the development of new drugs, new imaging techniques, and advanced methods of diagnosis as well as research that will improve the quality of life of brain tumor patients and their caregivers.
• Eligibility: Applicants must already be located at their mentor’s institution at the time of LOI
  submission; LOIs must include a career development plan. Mentor faculty must confirm that their institution considers their position equivalent to a faculty position if they do not follow traditional academic rank titles (e.g., Professor, Associate Professor).

America Brain Tumor Association  – Discovery Grants

• Due : December 10, 2025 (LOI)
• Funding: Up to $50,000
• Project Period: 1 year
• Purpose: To support novel, high-risk/high-impact faculty projects that have potential to change current diagnostic or treatment paradigms for adult and pediatric brain tumor care (investigators from sciences outside traditional biological fields encouraged to apply). Projects focused on all brain tumor types, benign or malignant, primary, or secondary (metastatic), and those that will have an impact on pediatric, adult, or both populations are encouraged.
• Eligibility: Applicants must currently be in a faculty position at the time of LOI submission
  (December 10, 2025) and be no more than eight years from the start of the first faculty
  position by September 1, 2026. PI or mentor faculty must confirm that their institution considers their position equivalent to a faculty position if they do not follow traditional academic rank titles (e.g., Professor, Associate Professor).

America Heart Association  – 2026 Innovative Project Award

• Due : December 10, 2025 (Pre-proposal deadline)
• Funding: $200,000
• Project Period: 2 years
• Purpose: To support highly innovative (that introduces new a paradigm, challenges current paradigms, looks at existing problems from new perspectives, or exhibits other uniquely creative qualities), high-impact research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and/or cerebrovascular research.
• Eligibility: AHA membership required. Applicants must hold an MD, PhD, DO, DVM, DDS, PharmD, PhD in Nursing, public health, or other clinical health science, or equivalent. They must hold a faculty/staff position no higher than an assistant professor level (no more than 6 years past the first faculty/staff position), and must work or be affiliated with a U.S.-based non-profit institution. U.S. citizens, permanent residents, pending permanent residents whose applications have been received by USCIS and case pending and those with other types of visa status (see RFA) may apply.

Pfizer Competitive Grant Program – Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research Collaboration

• Due: December 11, 2025
• Funding: Up to $500,000
• Project Period: 1 year
• Purpose: To identify and collaborate with investigators to conduct studies aimed at estimating the CDI disease burden.
• Eligibility: PI applicants must have an MD, PhD, MD/PhD, advanced nursing degree (BSN with a MS/PhD), PharmD, or an advanced degree in Physiotherapy or Social Work (or the equivalent). The institution and PI must live in France, Germany, Japan, the U.K. or U.S. and must be willing and able to engage in a research collaboration with Pfizer. The organization must be legally able to receive award funding directly from Pfizer Inc.

RUNX1 Research Grant Program & Alex’s Lemonade Stand Foundation for Childhood Cancer – RUNX1 RARE Grant Program – Research Accelerating RUNX1 Exploration

• Due : December 11, 2025
• Funding: $250,000
• Project Period: Over 2 years
• Purpose: To fund research that will accelerate development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevent blood cancer (before clonal hematopoiesis).
• Eligibility: Applicants must have MD, PhD, MD/PhD (DO, MBBS or equivalent) and research experience working in, and a deep understanding of, normal or malignant hematopoiesis and/or immunology. Funds will be granted to non-profit organizations only. PIs can have other grants during the award period but must provide clear documentation of mechanisms to avoid scientific and budgetary overlap.

Orthopaedic Research and Education Foundation – OREF Osteoarthritis Research Grant

• Due : December 15, 2026 (LOI)
• Funding: $50,000
• Project Period: Not specified
• Purpose: To support research that aims to help advance understanding of better prevention and treatment methods for osteoarthritis.
• Eligibility: Open to new investigators (investigators who have not received an NIH R01 or its equivalent). An orthopedic surgeon PI must be licensed to practice in the U.S. and be working at a U.S.-based institution. A PhD may serve as PI if they have a primary or secondary faculty appointment in an orthopedic department and submit a letter from the department chair confirming this appointment. DVMs are eligible to apply. Multidisciplinary research is encouraged.

Orthopaedic Research and Education Foundation – OREF/ASES Rockwood Clinical Shoulder Research Grant

• Due : December 15, 2026 (LOI)
• Funding: $50,000
• Project Period: Not specified
• Purpose: To support new investigators conducting research in shoulder care.
• Eligibility: Intended for new investigators (classified as an individual who has not received an R01 NIH grant or its equivalent. Either the PI or co-PI must be a member of the American Shoulder and Elbow Surgeons. An orthopedic surgeon PI must be licensed to practice in the U. S. and work at a U.S.-based institution. A PhD may serve as the PI if they hold a faculty appointment in an orthopedic department at a U.S.-based institution. A letter from the department chair confirming the appointment is required.

American Association for Cancer Research – Breast Cancer Research Foundation-AACR Career Development Awards

• Due: December 16, 2025 (LOI)
• Funding: $150,000
• Project Period: 2 years
• Purpose: A joint effort to support innovative basic, translational, clinical, or population-based research with direct relevance and applicability to breast cancer research.
• Eligibility: Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field, hold a faculty position as an assistant professor, instructor, research assistant professor, or the equivalent, appointed within the past 6 years from grant start date (if eligibility is based on a future position, the position must be confirmed at the time of application and CANNOT be contingent upon receiving this grant). Applicants must work at an academic, medical, or research institution and have independent lab space (confirmed by their institution).

American Association for Cancer Research – Breast Cancer Research Foundation and Lobular Breast Cancer Alliance-AACR Career Development Award

• Due: December 16, 2025 (LOI)
• Funding: $150,000
• Project Period: 2 years
• Purpose: A joint effort to support innovative research led by early-career investigators focused on basic, translational, clinical, or population-based research that will have direct applicability and relevance to invasive lobular carcinoma (ILC).
• Eligibility: Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field, hold a faculty position as an assistant professor, instructor, research assistant professor, or the equivalent, appointed within the past 6 years from grant start date (if eligibility is based on a future position, the position must be confirmed at the time of application and CANNOT be contingent upon receiving this grant). Applicants must work at an academic, medical, or research institution and have independent lab space (confirmed by their institution).

Jay L. Smith Foundation – Grants

• Due : December 31, 2025 (pre-proposal)
• Funding: Not specified
• Project Period: 1 year
• Purpose: To support research, programs, education and outreach in various areas to include dementia & Alzheimer’s disease, health care access and delivery, elderly care, suicide prevention, and cancer research.
• Eligibility: U.S.-based nonprofit organizations may apply.

Awards

February

Lasker Foundation – 2026 Lasker Awards: Call for Nominations

• Nominations Due : February 2, 2026
• Prize: Not specified
• Purpose: Albert Lasker Basic Medical Research Award honors fundamental discoveries that lead to a new area of biomedical science. The Lasker-Debakey Clinical Medical Research Award honors major advances that improve the lives of many thousands of people. The Lasker-Koshland Special Achievement Award in Medical Science recognizes research accomplishments and scientific statesmanship that engender the deepest feelings of awe and respect (this award will be given in 2027). The Lasker-Bloomberg Public Service Award recognizes outstanding public services improvements, policy initiatives that accelerate progress in medical science or health and increasing public health knowledge
• Eligibility: Applicants with a demonstrated track record of making an original and significant contribution in basic or clinical medical research, or in public service, or whose work opens new areas of biomedical science or public service may apply

January

American Association for Cancer Research & Lustgarten Foundation – Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg

• Due: January 6, 2026
• Funding: $300,000
• Project Period: 3 years
• Purpose: A joint effort between AACR and the Lustgarten Foundation to support career advancement of early scientists conducting pancreatic cancer research and to encourage innovative ideas in basic, translational, clinical, or population sciences research focused on understanding, detecting, diagnosing, or treating pancreatic cancer. Open to researchers currently working in the field and those from other areas of cancer or biomedical research whose work has applicability to pancreatic cancer research.
  Eligibility: Applicants must hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field, be an AACR Active member in good standing, have a faculty appointment as assistant professor or equivalent, possess independent laboratory space and funding capabilities as verified by their institution, and work at an academic, medical, or research institution globally by July 1, 2026.

American Association for Cancer Research & Lustgarten Foundation – Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in Honor of John Robert Lewis

• Due: January 6, 2026
• Funding: $300,000
• Project Period: 3 years
• Purpose: A joint effort between AACR and the Lustgarten Foundation to support career advancement of a scientist conducting pancreatic cancer research related to the areas of basic, translational, clinical, or population sciences that have direct applicability and relevance to the understanding, detection, diagnosis, or treatment of pancreatic cancer.
• Eligibility: Applicants must hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field, be an AACR Active member in good standing, have a faculty appointment as assistant professor or equivalent, possess independent laboratory space and funding capabilities as verified by their institution, and work at an academic, medical, or research institution globally by July 1, 2026.

American Association for Cancer Research & Torrey Coast Foundation – AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant

• Due: January 6, 2026
• Funding: $400,000
• Project Period: 2 years
• Purpose: A joint effort between AACR and the Torrey Coast Foundation to support a multi-institutional team with PIs from at least one institution in the U.S. and one in Asia that will conduct collaborative, translational research in gastric or esophageal cancer, specifically in areas like resistance, metastasis, innovative treatment strategies, (including identifying and characterizing novel targets), and cellular and immunotherapies. An estimated timeline for implementation in clinic must be included in the proposal.
• Eligibility: Applicants must hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field, be an AACR Active member in good standing, have a faculty appointment as assistant professor or equivalent, possess independent laboratory space and funding capabilities as verified by their institution, and work at an academic, medical, or research institution globally by July 1, 2026.

Ono Pharma Foundation – The Ono  Initiative

• Due: February 13, 2026 (LOI); January 6, 2026 internal application deadline for VU/VUMC applicants
• Funding: Up to $1,035,000
• Project Period: Over 3 years
• Purpose: To support academic research in relevant scientific fields, which have the potential of making significant impact on therapeutic approaches to disease and pain management. Only proposal addressing Chemical Biology Research will be considered.
• Eligibility: Only proposal addressing Chemical Biology Research will be considered. Applicants must have an MD and/or a PhD with 15 years or less of experience from starting their independent academic position, be a new applicant to Ono, or, if returning, apply with a different project. The PI must not be a healthcare professional (defined as individuals currently holding an active state license or which they are (a) qualified to prescribe, administer, use or supply any medicinal or medical products or (b) perform any professional clinical services).
• Note: VU/VUMC applicants must apply by January 6, 2026 through the Vanderbilt-wide Limited Submission Opportunity 2026 Ono Pharma Breakthrough Science Initiative Awards.

Cancer Research Institute (CRI) – CRI IGNITE Award

• Due: January 9, 2026
• Funding: $1.05M
• Project Period: Up to 5 years (phase 1: 2 years; phase 2: 3 years)
• Purpose: To support the transition of exceptional postdoctoral researchers into independent tenure-track investigators. This program provides early-career funding to catalyze research independence and long-term career success in cancer immunotherapy, complementing institutional resources and ensuring sustained productivity.
• Eligibility: Applicants must be in a mentored postdoctoral position, have no more than 5 years of mentored research experience by award date, and commit to a minimum of 12 months of mentored research before transitioning to independence. Applicants are not eligible if they hold or previously held an independent research faculty or tenure-track faculty position or the equivalent. Phase 2 candidates require at least 12 months phase 1 completion and a secured tenure-track assistant professor position (or equivalent) with a strong institutional commitment, including at least 65% protected time.

International Foundation for Gastrointestinal Disorders – IFFGD 2026 GI Research Grant

• Due: January 11, 2026
• Funding: $40,000
• Project Period: Up to 5 years (phase 1: 2 years; phase 2: 3 years)
• Purpose: To support innovative research that will ultimately lead to improvements in the understanding of gastrointestinal disorders, its pathophysiology, and the care of patients.
• Eligibility: Applicants must have completed an MD or PhD (or equivalent) received not more than ten years prior to application, have a record of relevant research accomplishment, and be currently active in investigating basic or clinical aspects of gastrointestinal illness within the IFFGD portfolio.

Simons Foundation – Fellows-to-Faculty Award

• Due: January 14, 2026
• Funding: $600,000
• Project Period: 3 years
• Purpose: To support talented early career scientists in the autism & neuroscience research field by facilitating their transition into tenure-track faculty positions. It allows fellows to engage with a community of investigators and receive mentoring and peer support during their transition.
• Eligibility: Applicants must have a PhD and/or MD and currently hold a mentored research training position with the intention of pursuing a tenure-track research faculty position during the upcoming academic job cycle. Applicants must have a scientific vision for their future independent laboratory that advances the mission of the Simons Foundation Autism Research Initiative (SFARI) or Simons Collaboration on Plasticity and the Aging Brain (SCPAB).

Cancer Research Institute (CRI) – CRI Lloyd J. Old STAR Program

• Due: January 15, 2026
• Funding: $1.25 million
• Project Period: Up to 5 years
• Purpose: To support mid-career scientists pursuing high-risk, high-reward research in cancer immunotherapy by providing long-term, flexible funding to enable bold, innovative scientists to explore unconventional research paths that have potential to lead to transformative breakthroughs.
• Eligibility: Applicants must hold an MD, PhD, or MD/PhD, or equivalent and have a tenure-track position (this includes assistant professors with a minimum of 3 years in their position who were appointed on or before July 1, 2023 and associate professors with a maximum of 3 years in their position who were appointed on or after July 1, 2023. Adjunct or acting positions are not eligible. 80% protected time required. For-profit institutions are not eligible.

Simons Foundation – Scientific Software Research Faculty Award

• Due: January 21, 2026 (LOI)
• Funding: Up to $250,000
• Project Period: Up to 5 years
• Purpose: To support new research professor positions for scientific software-focused researchers (e.g., “clinical professor,” “professor of practice” or “research professor,” or equivalent) in existing academic departments of host institutions. Researchers must have a strong track record of leadership in scientific software development.
• Eligibility: Applicants must have a PhD or equivalent in mathematics, astronomy or theoretical physics and have played a leading role in developing or maintaining scientific software in one or more of these fields. Awardees must be hired into a new clinical professor, professor of practice or equivalent-level positions in a mathematics, astronomy, physics or similar department where 50 percent of their time is committed to teaching and/or supporting computational efforts within the department.

American Association for Cancer Research (AACR) – AACR Non-Small Cell Lung Cancer Research Fellowship

• Due: January 22, 2026 (LOI)
• Funding: $130,000
• Project Period: 2 years
• Purpose: To support the salary and benefits of the fellow while working on a non-small cell lung cancer research project.
• Eligibility: Applicants must have a terminal degree, PhD, MD, MD/PhD, or equivalent in a related field, completed within the past five years (not before August 1, 2021–residency included). As of August 1, 2026, applicants must hold a mentored research position (postdoctoral fellow, clinical research fellow, or equivalent) or have a confirmed future position that is not contingent on receiving the grant. AACR membership and working under the direction of a mentor at an academic, medical, or research institution is required.

American Heart Association – Rapid Impact Research Award

• Due: January 22, 2026
• Funding: $50,000/year
• Project Period: 2 years
• Purpose: To support early and mid-career investigators proposing novel, innovative basic, clinical and/or population health focused research that aligns with the Association’s mission (areas of focus: sudden /cardiac arrest/resuscitation science, Cardiovascular Kidney Metabolic Syndrome, and Stroke and/or vascular dementia.
• Eligibility: Applicants must hold an MD, PhD, DO, DVM, DDS, DNP, or equivalent post-baccalaureate doctoral degree and be at the faculty level of instructor, assistant professor, or associate professor. Holding a full-time faculty/staff scientist position equivalent to one of these listed positions is also acceptable. Awardees may concurrently hold an NIH K award, other than K99/R00, if there is no budgetary overlap.

American Society of Clinical Oncology – Young Investigator Award Special Competitions

• Due: January 29, 2026
• Funding: $50,000
• Project Period: 1 year
• Purpose: This is a mentored award to support physicians during the transition from a fellowship program to a faculty appointment.
• Eligibility: Applicants must be working in an oncology lab or clinical research setting and be a physician (MD, DO, or international equivalent) with a valid, active medical license, working in any country, who plans on pursuing a career in oncology research. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period. Applicants must be within the last two years of their final oncology subspecialty training or fellowship program, within 10 years of obtaining their medical degree at an academic medical institution at the time of application submission, ASCO membership required (membership application submitted within the grant application is allowed). 60% protected time required and a mentor from the sponsoring institution is required.

American Board of Medical Specialties Research and Education Foundation – 2026-2028 Independent Research Grant

• Due: January 30, 2026 (LOI)
• Funding: $75,000
• Project Period: 2 years
• Purpose: To support independent, novel research that will help to provide insights and guide improvements in the structures, processes, and outcomes of medical specialty certification processes of the ABMS Member Boards.
• Eligibility: Applications will be accepted from health systems, universities, or other organizations with missions that intersect with the ABMS mission. The PI’s primary organization must be based in the U.S. The PI must be affiliated with ABMS.

American Parkinson Disease Association – George C. Cotzias, MD, Memorial Fellowships

• Due: January 30, 2026 (LOI)
• Funding: Up to $125,000 annually
• Project Period: Up to 3 years
• Purpose: To aid promising young neurologist in establishing careers in research, teaching and patient care related to the problems, causes, prevention, diagnosis and treatment of Parkinson’s disease and associated neurological movement disorders. 
• Eligibility: Applicants must be licensed physicians who are able to practice medicine in the U.S. and who are completing, or have completed, training in a clinical discipline related to disorders of the nervous system (i.e. adult neurology, child neurology, neurosurgery, neuropathology), at the instructor or assistant professor level at a U.S institution and must demonstrate a clear commitment to the fellowship’s purpose.

Society of Nuclear Medicine & Molecular Imaging – 2026 Mitzi & William Blahd, MD Pilot Research Grant

• Due: January 30, 2026 (pre-proposal)
• Funding: $25,000
• Project Period: Not specified
• Purpose: To help basic or clinical scientists in the early stages of their career conduct pilot research that may lead to further funding.
• Eligibility: Applicants with an MD, PhD, or equivalent, with no more than five years post training (including residency, MD, doctorate training, professional school, graduate school, postdoc or fellowship). Applicants who have served as a PI of a peer-reviewed grant of more that $50,000 in one calendar year are not eligible.

American Academy of Audiology Foundation and the American Academy of Audiology – Investigator Research Grant

• Due: January 31, 2026
• Funding: $20,000
• Project Period: 1 year
• Purpose: To support basic and applied research in hearing and balance that will benefit people with hearing loss and/or balance deficits by improving the ability of professionals in audiology to evaluate and manage hearing and balance disorders.
  Eligibility: Applicants must have a doctoral degree in audiology or hearing science; post-doctorate fellows (AuD and PhD) applicants are encouraged to apply. PIs must not have current or past significant source of research funding in the proposed area of research.

February

Gerber Foundation – 2026 Novice Research Awards

• Due: February 2, 2026 (Concept paper due)
• Funding: Up to $30,000
• Project Period: Up to 2 years
• Purpose: To support PIs who are considered new to research.
• Eligibility: Applicants who are physicians, PhD candidates, PharmD candidates, and other similar degree candidates (in a residency, postdoctoral, or fellowship training program or those who are no more than one year post training) and those who have not yet received an NIH K award or equivalent may apply. A mentor and a current development plan are required for the project.

Gerber Foundation – 2026 Pediatric Major Research Awards

• Due: February 2, 2026 (Concept paper due)
• Funding: Up to $350,000
• Project Period: Up to 3 years
• Purpose: To support experienced PIs conducting projects that will result in new information, treatments, or tools that can be easily and quickly implemented on a broad scale with a predictable timeline to clinical application.
  Eligibility: Grants will be made to tax-exempt organizations only.

Jane Coffin Childs Fund – Jane Coffin Childs Fund Postdoctoral Fellowship

• Due: February 2, 2026
• Funding: $72,000 stipend year 1; $74,000 year 2; $76,000 year 3
• Project Period: 3 years
• Purpose: To support outstanding postdoctoral researchers who demonstrate exceptional potential for independent research that will advance the field of biomedical science, and to foster development of successful independent researchers by providing funding for innovative research projects conducted under the mentorship of qualified postdoctoral advisors.
• Eligibility: Postdoctoral applicants must have 12 months or less of postdoctoral experience by February 2, 2026, with their first postdoc position starting no earlier than February 2, 2025. Ph.D. and MD applicants must have received their degrees no earlier than February 2, 2024, and February 2, 2023, respectively. PhD candidates without a degree by the deadline may apply but must complete their PhD and start the fellowship by July 1, 2026. Postdoctoral training at the same institution or department as the applicant’s PhD is discouraged. Proposals from the same laboratory will not be funded. Applicants who have accepted a postdoctoral fellowship are ineligible but T32 recipients may apply. Non-U.S. citizens may apply with sponsorship from a U.S.-based institution. Proof of commitment from a sponsoring lab and institution, not reliant on the fellowship award, is required.

Cooley’s Anemia Foundation – 2026-2027 Research Fellowship

• Due: February 9, 2026
• Funding: $50,000/year
• Project Period: 1 year (renewable for 1 additional year w/ demonstrated progress)
• Purpose: To support innovative clinical and basic science investigators, both nationally and internationally, in advancing the understanding and treatment of thalassemia and its related complications. Research areas include globin gene regulation, gene transfer, fetal hemoglobin production, hematopoietic stem cell research, bone marrow transplantation, iron chelation, cardiac and endocrine disorders, and transfusion therapy.
  Eligibility: Awarded to non-profit medical institutions. Postdoctoral researchers and junior faculty members who hold an MD, PhD, or equivalent may apply. Postdoctoral applicants must work under the guidance of an experienced sponsor at an institution with sufficient research resources (the proposal must be the candidate’s original work developed with input from their mentor).

Beatson Foundation – Grant Application Request

• Due: February 13, 2026
• Funding: Up to $125,000 annually
• Project Period: Up to 2 years
• Purpose: To support innovative research by outstanding biomedical researchers who hold an academic rank of Senior Instructor, Assistant Professor or higher from accredited institutions for the 2026 “Passion to Find a Cure” Program, to increase understanding and find a cure for Type 1 Diabetes. High priority areas include: beta cell transplantation and regeneration, autoimmunity issues, diabetes related complications and management of T1D using devices.
• Eligibility: Applicants who hold an academic rank of Senior Instructor, Assistant Professor or higher from accredited institutions are eligible.

Orthopaedic Research and Education Foundation – OREF Mentored Clinician Scientist

• Due: February 16, 2026
• Funding: $20,000
• Project Period: 1 year (renewable for 1 additional year w/ demonstrated progress)
• Purpose: To support the development of new clinician scientists who have demonstrated success as both a clinician and a researcher by allowing them to spend dedicated time in research for a period of up to five years to build a successful career in academic surgery.
• Eligibility: Awarded to non-profit medical institutions. Postdoctoral researchers and junior faculty members who hold an MD, PhD, or equivalent may apply. Postdoctoral applicants must work under the guidance of an experienced sponsor at an institution with sufficient research resources (the proposal must be the candidate’s original work developed with input from their mentor).

Orthopaedic Research and Education Foundation – OREF/Musculoskeletal Transplant

• Due: February 16, 2026
• Funding: $100,000
• Project Period: 2 years
• Purpose: To support investigator-initiated proposals focusing on research in the science of biologic – reconstruction, bone regeneration, transplantation – allografts, and including stem cells for graft transplantation.
• Eligibility: Open to new investigators who have demonstrated sustained interest in research and excellence in their training. Multidisciplinary research activity is strongly encouraged. An orthopedic surgeon PI must be licensed to practice in the U. S. and be working at a U.S.-based institution. PIs can hold a PhD and must hold a faculty appointment in an orthopedic department at a U.S.-based institution.

Wellcome Early Career Awards – Wellcome Early Career Awards

• Due: February 16, 2026
• Funding: Salary and up to £400,000 for research expenses (plus other allowable expenses)
• Project Period: Up to 5 years
• Purpose: To support early-career researchers in designing, planning, and delivering innovative research projects that advance understanding in their field or develop methodologies, tools, or techniques to benefit health-related research, and to help early career researchers develop skills and leadership needed to lead independent research programs or develop transferable skills for careers outside academia, such as industry or teaching.
• Eligibility: Applicants must have completed a PhD or equivalent higher research degree by the application deadline or have at least four years of equivalent research experience if they have not pursued a higher research degree. Postdoctoral experience is permitted but must not exceed three years unless justified (e.g., career breaks, part-time work, or changes in research discipline). 80% protected time required with allowances for clinical duties or teaching up to 20%. Health professionals must be registered and licensed by the relevant professional regulator in their country. Applicants from low- or middle-income countries can hold permanent contracts but must meet all other criteria. The award may be held on a part-time basis.

The American Headache Society & Pfizer – Headache & Migraine Competitive Grant Program: Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders

• Due: February 25, 2026 (LOI)
• Funding: Up to $250,000
  
• Project Period: Up to 2 years
• Purpose: To support quality improvement projects that have measurable outcomes and lead to information or tools that can be shared and used widely for improving the lives of people impacted by migraine and other headache disorders. Multidisciplinary collaborations are allowed. High priority will be given to projects explicitly focused on system changes.
• Eligibility: Applicants at medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other organizations with a mission related to healthcare improvement may apply. American Headache Society membership required. Requesting organizations must be legally able to receive award funding directly from Pfizer Inc.

March

Cancer Research Institute (CRI) – CRI Immuno-Informatics Postdoctoral Fellowship

• Due: March 2, 2026
• Funding: $243,000
• Project Period: 3 years
• Purpose: To support early-career scientists aiming to combine expertise in immunology and data science. It fosters innovation in cancer immunotherapy by training researchers at the intersection of computational biology, genomics, and immunology to address critical gaps in understanding the immune system’s role in cancer.
• Eligibility: Applicants must have a doctoral degree and 5 years or less of mentored research experience by award activation date. No citizenship requirements but fellowship must take place at a non-profit U.S. institution.

Cancer Research Institute (CRI) – CRI Irvington Postdoctoral Fellowship Program

• Due: March 2, 2026
• Funding: $243,000
• Project Period: 3 years
• Purpose: To support outstanding postdoctoral researchers in immunology and cancer immunology at leading institutions worldwide. It aims to provide resources, mentorship, and professional development to help fellows transition from doctoral training to independent scientific careers, fostering groundbreaking research on the immune system’s role in cancer and cancer immunotherapy.
• Eligibility: Applicants must have a doctoral degree and 5 years or less of mentored research experience by award activation date (excluding M.D. residency); fellowship applicants can have no more than 3 years in their sponsor’s lab by the fellowship start date.